Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
33.36    0.36 (1.09%)
Bid:
33.16
Ask:
33.42
Spread: 0.26 (0.784%)
Market Cap: £529.37m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Further Trading Update

11 Aug 2005 07:00

Terrace Hill Group PLC11 August 2005 TERRACE HILL GROUP PLC ("Terrace Hill") Further Trading Update Following a confidentiality period, Terrace Hill can now add to the tradingupdate published on 21 July 2005 for the third quarter to 31 July 2005 of itscurrent financial year. Terrace Hill is pleased to report that on 18 July 2005 it agreed to sell theTemple Circus office being developed in joint venture in Bristol for £25.75million on completion of construction expected in August 2006. The sevenstorey 91,000 sq. ft. development near Temple Mead Station, is being sold toCorporate Centres GP Ltd, the fund formed by BriTel and Norwich Union andoperated by Morley Fund Management. AIM listed service office providersStonemartin will operate the building on its completion. In Scotland, without advertising having yet commenced, reservations have beentaken for more than half of the 54 residential flats under development atGlasgow Green, Glasgow. In addition to the flats, this development comprises 10further units including four terraced houses being created by the refurbishmentof a listed school house. The reservations include the whole of the first blockof eight flats due to be completed before the end of the current year. Thelarger block of 46 flats is expected to be completed in November 2006. Managing Director Philip Leech said "For a property developer there is nothingfiner than to sell developments a year in advance of completion. In Bristol ithas been obvious from demand that Temple Circus was possibly the largest andcertainly one of the most attractive buildings coming on stream in the nearfuture." The previous trading update on 21 July 2005 included the sale of a joint ventureproperty at 16 Berkeley Street, London for £39.4 million and the sale of aninvestment property acquired with Grosvenor Land Holdings PLC in Maidstone for£6.4 million. At the same time, Terrace Hill also announced the acquisition offurther Brownfield land for potential housing development in Scotland. * * ENDS * * For further information please contact: Ross Macdonald, Deputy Chairman, 07710 459 649Nigel Turnbull, Deputy Chairman 0207 631 1666Alasdair Robinson, Noble & Company Limited, 0131 225 9677 Notes to editors: Terrace Hill Group PLC is an AIM traded Property Group with NAV £74 million. Ithas two divisions, Commercial Development throughout the UK and ResidentialInvestment and Development in Scotland and the North of England, with adevelopment programme of some £600 million. Terrace Hill reported an increaseof over 25% in both NAV and pro-forma Triple NAV to 38.12p per share and 39.99prespectively in the year to 31 October 2004, and an increase in final dividendfrom 0.15p per share to 0.50p per share. Further increases to 39.66p per shareand 44.02p per share respectively together with an interim dividend of 0.5p pershare (previous interim 0.3p) were announced with the Group's half yearly reportto 30 April 2005. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM
21st Apr 20267:00 amRNSTrading Statement
20th Apr 20264:45 pmRNSNotice of Q1 Trading Update
8th Apr 20267:00 amRNSAnnual Report & Accounts 2025
26th Mar 20267:00 amRNSPreliminary FY 2025 results
25th Mar 20264:54 pmRNSNotice of Results
24th Feb 20267:45 amRNSPDMR/PCA Shareholding & TR-1 Notification
12th Feb 20267:00 amRNS-RMyprotein licensing partnership with Greencore
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20263:49 pmRNSTR-1: Notification of major holdings
27th Jan 20263:45 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20262:52 pmRNSTR-1: Notification of Major Holdings
22nd Jan 20263:00 pmRNSApplication for Listing and Total Voting Rights
16th Jan 20267:00 amRNSChange to Board Committee Membership
13th Jan 20267:00 amRNSQ4 2025 Trading Statement
12th Jan 20264:40 pmRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
16th Dec 20255:50 pmRNSTR-1: Notification of Major Holdings
9th Dec 20254:35 pmRNSTR-1: Notification of Major Holdings
9th Dec 202510:55 amRNSTR-1: Notification of Major Holdings
9th Dec 20259:15 amRNSPDMR/PCA Shareholding & TR-1 Notification
5th Dec 202510:15 amRNSDirector Declaration
5th Dec 202510:05 amRNSAdmission of Convertible Loan Shares and TVR
26th Nov 20259:45 amRNSPDMR/PCA Shareholdings
17th Nov 20257:00 amRNS-RMyprotein joins forces with Mars
3rd Nov 20257:00 amRNSBlock listing Interim Review
28th Oct 202511:14 amRNSDirector Declaration
14th Oct 20257:00 amRNSQ3 2025 Trading Statement
10th Oct 20257:00 amRNSNotice of Trading Update
19th Sep 20256:00 pmRNSOcean Wilsons
11th Sep 20257:00 amRNSInterim results for half-year ended 30 June 2025
10th Sep 20254:45 pmRNSNotice of Interim Results
5th Sep 20257:00 amRNSNotification under UKLR 6.4.9R(2)
6th Aug 20257:42 amRNSDisposal, H1 trading and Nutrition update - Amend
6th Aug 20257:00 amRNSDisposal, H1 trading and Nutrition update
9th Jul 20252:24 pmRNSChanges to Directors’ Responsibilities
25th Jun 20252:38 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Statement
5th Jun 20253:56 pmRNSTR-1: Notification of Major Holdings
23rd May 20257:00 amRNSNotice of AGM
1st May 20257:00 amRNSBlock Listing Six Monthly Return
30th Apr 20257:00 amRNSAnnual Report & Accounts 2024
29th Apr 20257:00 amRNSFY 2024 results and Q1 trading statement
23rd Apr 20257:00 amRNSResponse to media speculation
16th Apr 20254:45 pmRNSTR-1: Notification of Major Holdings
4th Apr 202510:30 amRNSTR-1: Notification of Major Holdings
4th Apr 20257:00 amRNSCompletion of debt refinancing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.